Showing results (121-130 of 548) with videos related to
Sort By:
Pageof 55
Therapeutic Advances in Psychopharmacology|September 4, 2023
Managing medical and psychiatric multimorbidity in older patientsDavid M Carlson, Brandon C YarnsTherapeutic Advances in Psychopharmacology|September 13, 2023
Anticholinergic action is rarely a good thingDelia BisharaTherapeutic Advances in Psychopharmacology|June 8, 2026
Cariprazine augmentation for negative symptoms of schizophrenia: a prospective analysis and literature reviewEwa Okon-Rocha, David TaylorTherapeutic Advances in Psychopharmacology|July 2, 2026
Readability of informed consent forms from ClinicalTrials.gov in ketamine clinical trials for mental health conditions: a cross-sectional analysisDamian Swieczkowski, Aleksander Kwaśny, Wiesław Jerzy CubałaTherapeutic Advances in Psychopharmacology|July 9, 2026
Making a case for using MDMA-assisted psychotherapy for borderline personality disorder and complex PTSD: a descriptive systematic review of the literatureKarthika Kasiviswanathan, Dinuli Nilaweera, Melissa Morando, et al.Therapeutic Advances in Psychopharmacology|May 25, 2026
Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physiciansKristian Beichmann, Polina Catzeflis, Helena D Aicher, et al.Therapeutic Advances in Psychopharmacology|August 1, 2026
Seizures associated with clozapine augmentation by other antipsychotics: a pharmacovigilance-pharmacodynamic analysis using VigiBaseMasakazu Hatano, Hirofumi Hamano, Masaya Kanda, et al.Therapeutic Advances in Psychopharmacology|July 25, 2026
A qualitative exploration of perspectives on taking lithium supplementsMadeleine Bloomfield, Lily Chebabo-Manning, Rebecca StrawbridgeTherapeutic Advances in Psychopharmacology|August 25, 2026
Clinical response to clozapine in Black people with psychosis: A secondary analysis of an open-label clinical trialAllison S Brandt, Gopal Vyas, Taiwo Oduguwa, et al.Therapeutic Advances in Psychopharmacology|November 24, 2022
Increased left dorsolateral prefrontal cortex density following escitalopram intake during relearning: a randomized, placebo-controlled trial in healthy humansThomas Vanicek, Murray B Reed, René Seiger, et al.Pageof 55